Syndax Pharmaceuticals Inc (35) | Business Finance (14)
Browse by Subcategory
Recent Contracts
-
First Amendment to the Companys Loan and Security Agreement with the several banks and financial institutions or entities from time-to-time party thereto and Hercules Capital,...
(Filed With SEC on March 1, 2022)
-
Form of Pre-Funded Warrant (2021)
(Filed With SEC on December 17, 2021)
-
Underwriting Agreement, dated December 15, 2021, by and among the Company and Goldman Sachs & Co. LLC
(Filed With SEC on December 17, 2021)
-
Stock Purchase Agreement by and between the Company and Incyte Corporation, dated as of September 24, 2021
(Filed With SEC on November 15, 2021)
-
Purchase Agreement between the Company and the Purchasers, dated January 30, 2020
(Filed With SEC on February 4, 2020)
-
Underwriting Agreement, dated December 8, 2020, by and among the Company, Goldman Sachs & Co. LLC, Citigroup Global Markets Inc. and Cowen and Company, LLC
(Filed With SEC on December 9, 2020)
-
Loan and Security Agreement dated February 7, 2020 between Syndax Pharmaceuticals, Inc. and Hercules Capital, Inc
(Filed With SEC on May 7, 2020)
-
Underwriting Agreement, dated April 30, 2020, by and among the Company, Citigroup Global Markets Inc. and Cowen and Company, LLC
(Filed With SEC on May 4, 2020)
-
Description of Capital Stock
(Filed With SEC on March 5, 2020)
-
Form of Pre-Funded Warrant
(Filed With SEC on February 4, 2020)
-
Form of Series Warrant
(Filed With SEC on March 29, 2019)
-
Form of Pre-Funded Warrant
(Filed With SEC on March 29, 2019)
-
Purchase Agreement between the Company and the Purchasers, dated March 26, 2019
(Filed With SEC on March 29, 2019)
-
Purchase Agreement between the Company and the Purchaser, dated March 28, 2019
(Filed With SEC on March 29, 2019)